Related references
Note: Only part of the references are listed.Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
Irene Man et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Identification of HPV genotypes causing cervical precancer using tissue-based genotyping
Rebecca Venetianer et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Will HPV vaccination prevent cervical cancer?
Claire P. Rees et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2020)
Increase of cervical cancer incidence in Sweden in relation to screening history: population cohort study
Jiangrong Wang et al.
ACTA ONCOLOGICA (2020)
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2020)
Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas
Zurab Bzhalava et al.
VACCINE (2020)
Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women
Mario Preti et al.
INFECTIOUS AGENTS AND CANCER (2020)
HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
Andrea Ciavattini et al.
VACCINES (2020)
Adverse events following HPV vaccination: 11 years of surveillance in Australia
Anastasia Phillips et al.
VACCINE (2020)
Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: data mining of Vaccine Adverse Event Reporting System
Li Gong et al.
SCIENTIFIC REPORTS (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
HPV cervical infections and serological status in vaccinated and unvaccinated women
Carmen Lia Murall et al.
VACCINE (2020)
Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types
Martin Ryser et al.
EXPERT REVIEW OF VACCINES (2019)
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)
Penelope Gray et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016
Madleen Orumaa et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine
Andreas Ahrlund-Richter et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016
Nancy M. McClung et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Melanie Drolet et al.
LANCET (2019)
Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions
Can van Schalkwyk et al.
VACCINE (2019)
Detecting within-host interactions from genotype combination prevalence data
Samuel Alizon et al.
EPIDEMICS (2019)
Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort study
Carmen Lia Murall et al.
BMJ OPEN (2019)
Isolation of a Novel Beta-2 Human Papillomavirus from Skin
Rosario N. Brancaccio et al.
MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2019)
Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016)
Alexandre Blikstad Mauro et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2019)
Whole tissue cervical mapping of HPV infection: Molecular evidence for focal latent HPV infection in humans
Anne Hammer et al.
PAPILLOMAVIRUS RESEARCH (2019)
Epidemiological evaluation of human papillomavirus genotypes and their associations in multiple infections
Raffaele Del Prete et al.
EPIDEMIOLOGY AND INFECTION (2019)
Immune evasion mechanisms of human papillomavirus: An update
Alina Steinbach et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)
Penelope Gray et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis
Nicole S. L. Yeo-Teh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection
Jennifer Biryukov et al.
JOURNAL OF VIROLOGY (2018)
Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway
Bo T. Hansen et al.
BMJ OPEN (2018)
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
M. Arbyn et al.
EXPERT REVIEW OF VACCINES (2018)
Changes in human papillomavirus genotypes associated with cervical intraepithelial neoplasia grade 2 lesions in a cohort of young women (2013-2016)
Carrie R. Innes et al.
PAPILLOMAVIRUS RESEARCH (2018)
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database
David A. Geier et al.
IMMUNOLOGIC RESEARCH (2017)
HPV vaccines - A review of the first decade
Diane M. Harper et al.
GYNECOLOGIC ONCOLOGY (2017)
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Catherine de Martel et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Why Human Papillomavirus Acute Infections Matter
Samuel Alizon et al.
VIRUSES-BASEL (2017)
Natural History of HPV Infection across the Lifespan: Role of Viral Latency
Patti E. Gravitt et al.
VIRUSES-BASEL (2017)
The role of integration in oncogenic progression of HPV-associated cancers
Alison A. McBride et al.
PLOS PATHOGENS (2017)
Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes
T. Klymenko et al.
JOURNAL OF VIROLOGY (2016)
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
David Mesher et al.
EMERGING INFECTIOUS DISEASES (2016)
Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the M(a)over-barori and non-M(a)over-barori populations in New Zealand
Yoon-Jung Kang et al.
BMC INFECTIOUS DISEASES (2015)
Detection of Human Papillomavirus Infections at the Single-Cell Level
Zhenping Shen et al.
INTERVIROLOGY (2015)
HPV 16 E2 Binding Sites 1 and 2 Become More Methylated Than E2 Binding Site 4 During Cervical Carcinogenesis
Tsin-Wah Leung et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer
Karin Sundstrom et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer
Karin Sundstrom et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Could the human papillomavirus vaccines drive virulence evolution?
Carmen Lia Murall et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
Attributing Oncogenic Human Papillomavirus Genotypes to High-grade Cervical Neoplasia
Jacolien van der Marel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions
Emma T. Callegari et al.
VACCINE (2014)
Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases
Seiichiro Mori et al.
VIROLOGY JOURNAL (2014)
Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults
Lars Toft et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants
Serena Colafrancesco et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2013)
Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome
Jo L. K. Cheung et al.
GYNECOLOGIC ONCOLOGY (2013)
Prevalence and viral load of 51 genital human papillomavirus types and three subtypes
Markus Schmitt et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Viral and Cellular Biomarkers in the Diagnosis of Cervical Intraepithelial Neoplasia and Cancer
Maria Lina Tornesello et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Epithelial Cell Responses to Infection with Human Papillomavirus
Margaret A. Stanley
CLINICAL MICROBIOLOGY REVIEWS (2012)
Evolutionary Ecology of Human Papillomavirus: Trade-offs, Coexistence, and Origins of High-Risk and Low-Risk Types
Paul A. Orlando et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Methylation of Human Papillomavirus Type 16 Genome and Risk of Cervical Precancer in a Costa Rican Population
Lisa Mirabello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3
Nicolas Wentzensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Cosette M. Wheeler et al.
LANCET ONCOLOGY (2012)
Human Papillomavirus in Men: An Update
Anna-Barbara Moscicki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2011)
Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis
Chih-Ming Ho et al.
VIRUS RESEARCH (2011)
Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
Rolando Herrero et al.
CANCER DISCOVERY (2011)
Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy
Francesca M. Carozzi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Abundance of Multiple High-Risk Human Papillomavirus (HPV) Infections Found in Cervical Cells Analyzed by Use of an Ultrasensitive HPV Genotyping Assay
Markus Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
The EVER Proteins as a Natural Barrier against Papillomaviruses: a New Insight into the Pathogenesis of Human Papillomavirus Infections
Maciej Lazarczyk et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2009)
Human papillomavirus vaccines and the potential for cross-protection between related HPV types
Kevin A. Ault
GYNECOLOGIC ONCOLOGY (2007)
Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas
Adriana Balderas-Loaeza et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The natural history of cervical HPV infection: unresolved issues
Ciaran B. J. Woodman et al.
NATURE REVIEWS CANCER (2007)
Evidence for the coexistence of two genital HPV types within the same host cell in vitro
ME McLaughlin-Drubin et al.
VIROLOGY (2004)
Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade
G Hudelist et al.
GYNECOLOGIC ONCOLOGY (2004)
Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri
T Luostarinen et al.
EUROPEAN JOURNAL OF CANCER (2004)
Human papillomavirus and cervical cancer
EM Burd
CLINICAL MICROBIOLOGY REVIEWS (2003)
Share Paper
